Sugammadex and residual neuromuscular block: What is acceptable normal practice?

British Journal of Anaesthesia

Volumn 116, Issue 3, 2016, Pages 434-435

  Todd, M M ^a  

^a One Iowa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

EXTUBATION; HUMAN; INCIDENCE; LETTER; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; OBSERVATIONAL STUDY; PARALYSIS; PATIENT MONITORING; PEROPERATIVE CARE; PRIORITY JOURNAL; RECOVERY ROOM; ACCELEROMYOGRAPHY; ELECTROMYOGRAPHY; INTRAOPERATIVE MONITORING; MUSCLE TWITCH; NERVOUS SYSTEM PARAMETERS; QUANTITATIVE ANALYSIS; TRAIN OF FOUR RATIO; ANTAGONISTS AND INHIBITORS; DELAYED EMERGENCE FROM ANESTHESIA; DRUG EFFECTS; FEMALE; MALE; NEUROMUSCULAR JUNCTION;

ANDROSTANOLS; DELAYED EMERGENCE FROM ANESTHESIA; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 84960389167     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aew006     Document Type: Letter

References (9)

1. Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: A randomized, controlled study. Br J Anaesth 2015; 115: 743-51
2. Fortier LP, McKeen D, Turner K, et al. The RECITE Study: A Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg 2015; 121: 366-72
3. Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-54
4. Todd MM, Hindman BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department: follow-up observations. Anesth Analg 2015; 121: 836-8
5. Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg 2014; 119: 323-31
6. Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-51
7. Sasaki N, Meyer MJ, Malviya SA, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes. A prospective study. Anesthesiology 2014; 121: 959-68
8. Rahe-Meyer N, Fennema H, Schulman S, et al. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients. Anesthesiology 2014; 121: 969-77
9. Tassonyi E, Pongrácz A, Nemes R, Asztalos L, Lengyel S, Fülesdi B. Reversal of pipecuronium-induced moderate neuromuscular block with sugammadex in the presence of a sevoflurane anesthetic: A randomized trial. Anesth Analg 2015; 121: 373-80